APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plant-based Soft Capsules (Softgel)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plant-based Soft Capsules (Softgel) Market Outlook and Growth Opportunities 2026

Report ID 17347950042 January 2026193 pages

Choose your research edition.

Industry ResearchPlant-based Soft Capsules (Softgel) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Plant-based Soft Capsules (Softgel) Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Plant-based Soft Capsules (Softgel) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plant-based Soft Capsules (Softgel) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plant-based Soft Capsules (Softgel) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Plant-based Soft Capsules (Softgel) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plant-based Soft Capsules (Softgel) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plant-based Soft Capsules (Softgel) market include Catalent, Procaps Laboratorios, Eurocaps, Sirio Pharma (Best Formulations), Aenova, Captek, Bahrain Pharma, Robinson Pharma and Aland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Plant-based Soft Capsules (Softgel) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plant-based Soft Capsules (Softgel) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plant-based Soft Capsules (Softgel) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plant-based Soft Capsules (Softgel) market size, projected growth trends, production technologies, key applications, and end-use industries.

Plant-based Soft Capsules (Softgel) Segment by Company

Catalent

Procaps Laboratorios

Eurocaps

Sirio Pharma (Best Formulations)

Aenova

Captek

Bahrain Pharma

Robinson Pharma

Aland

Fuji Capsule

Sunsho Pharmaceutical

Erkang

Baihe Group

Plant-based Soft Capsules (Softgel) Segment by Type

Carrageenan

Starch

Gellan Gum

Plant-based Soft Capsules (Softgel) Segment by Application

Rx and OTC

Supplements

Other

Plant-based Soft Capsules (Softgel) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plant-based Soft Capsules (Softgel) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Plant-based Soft Capsules (Softgel) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plant-based Soft Capsules (Softgel) significant trends, drivers, influence factors in global and regions.

6. To analyze Plant-based Soft Capsules (Softgel) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Soft Capsules (Softgel) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plant-based Soft Capsules (Softgel) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Soft Capsules (Softgel).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Plant-based Soft Capsules (Softgel) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plant-based Soft Capsules (Softgel) industry.

Chapter 3: Detailed analysis of Plant-based Soft Capsules (Softgel) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Plant-based Soft Capsules (Softgel) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Plant-based Soft Capsules (Softgel) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plant-based Soft Capsules (Softgel) Industry Trends Table 2. Plant-based Soft Capsules (Softgel) Industry Drivers Table 3. Plant-based Soft Capsules (Softgel) Industry Opportunities and Challenges Table 4. Plant-based Soft Capsules (Softgel) Industry Restraints Table 5. Global Plant-based Soft Capsules (Softgel) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plant-based Soft Capsules (Softgel) Revenue Share by Company (2021-2026) Table 7. Global Plant-based Soft Capsules (Softgel) Sales Volume by Company (units) & (2021-2026) Table 8. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Company (2021-2026) Table 9. Global Plant-based Soft Capsules (Softgel) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Plant-based Soft Capsules (Softgel) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Plant-based Soft Capsules (Softgel) Key Company Manufacturing Base & Headquarters Table 12. Global Plant-based Soft Capsules (Softgel) Company, Product Type & Application Table 13. Global Plant-based Soft Capsules (Softgel) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Plant-based Soft Capsules (Softgel) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Carrageenan Table 18. Significant Companies of Starch Table 19. Significant Companies of Gellan Gum Table 20. Global Plant-based Soft Capsules (Softgel) Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 21. Global Plant-based Soft Capsules (Softgel) Sales Volume by Type (2021-2026) & (units) Table 22. Global Plant-based Soft Capsules (Softgel) Sales Volume by Type (2027-2032) & (units) Table 23. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Type (2021-2026) Table 24. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Type (2027-2032) Table 25. Global Plant-based Soft Capsules (Softgel) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Plant-based Soft Capsules (Softgel) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Plant-based Soft Capsules (Softgel) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Type (2021-2026) Table 29. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Rx and OTC Table 31. Significant Companies of Supplements Table 32. Significant Companies of Other Table 33. Global Plant-based Soft Capsules (Softgel) Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 34. Global Plant-based Soft Capsules (Softgel) Sales Volume by Application (2021-2026) & (units) Table 35. Global Plant-based Soft Capsules (Softgel) Sales Volume by Application (2027-2032) & (units) Table 36. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Application (2021-2026) Table 37. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Application (2027-2032) Table 38. Global Plant-based Soft Capsules (Softgel) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Plant-based Soft Capsules (Softgel) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Plant-based Soft Capsules (Softgel) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Application (2021-2026) Table 42. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Application (2027-2032) Table 43. Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021 VS 2025 VS 2032 (units) Table 44. Global Plant-based Soft Capsules (Softgel) Sales by Region (2021-2026) & (units) Table 45. Global Plant-based Soft Capsules (Softgel) Sales Market Share by Region (2021-2026) Table 46. Global Plant-based Soft Capsules (Softgel) Sales by Region (2027-2032) & (units) Table 47. Global Plant-based Soft Capsules (Softgel) Sales Market Share by Region (2027-2032) Table 48. Global Plant-based Soft Capsules (Softgel) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Plant-based Soft Capsules (Softgel) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Region (2021-2026) Table 51. Global Plant-based Soft Capsules (Softgel) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Region (2027-2032) Table 53. Global Plant-based Soft Capsules (Softgel) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Plant-based Soft Capsules (Softgel) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Plant-based Soft Capsules (Softgel) Sales by Country: 2021 VS 2025 VS 2032 (units) Table 56. Global Plant-based Soft Capsules (Softgel) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Plant-based Soft Capsules (Softgel) Sales by Country (2021-2026) & (units) Table 58. Global Plant-based Soft Capsules (Softgel) Sales Market Share by Country (2021-2026) Table 59. Global Plant-based Soft Capsules (Softgel) Sales by Country (2027-2032) & (units) Table 60. Global Plant-based Soft Capsules (Softgel) Sales Market Share by Country (2027-2032) Table 61. Global Plant-based Soft Capsules (Softgel) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Plant-based Soft Capsules (Softgel) Sales Value Market Share by Country (2021-2026) Table 63. Global Plant-based Soft Capsules (Softgel) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Plant-based Soft Capsules (Softgel) Sales Value Market Share by Country (2027-2032) Table 65. Catalent Company Information Table 66. Catalent Business Overview Table 67. Catalent Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Catalent Plant-based Soft Capsules (Softgel) Product Portfolio Table 69. Catalent Recent Development Table 70. Procaps Laboratorios Company Information Table 71. Procaps Laboratorios Business Overview Table 72. Procaps Laboratorios Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Procaps Laboratorios Plant-based Soft Capsules (Softgel) Product Portfolio Table 74. Procaps Laboratorios Recent Development Table 75. Eurocaps Company Information Table 76. Eurocaps Business Overview Table 77. Eurocaps Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Eurocaps Plant-based Soft Capsules (Softgel) Product Portfolio Table 79. Eurocaps Recent Development Table 80. Sirio Pharma (Best Formulations) Company Information Table 81. Sirio Pharma (Best Formulations) Business Overview Table 82. Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Product Portfolio Table 84. Sirio Pharma (Best Formulations) Recent Development Table 85. Aenova Company Information Table 86. Aenova Business Overview Table 87. Aenova Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Aenova Plant-based Soft Capsules (Softgel) Product Portfolio Table 89. Aenova Recent Development Table 90. Captek Company Information Table 91. Captek Business Overview Table 92. Captek Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Captek Plant-based Soft Capsules (Softgel) Product Portfolio Table 94. Captek Recent Development Table 95. Bahrain Pharma Company Information Table 96. Bahrain Pharma Business Overview Table 97. Bahrain Pharma Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Bahrain Pharma Plant-based Soft Capsules (Softgel) Product Portfolio Table 99. Bahrain Pharma Recent Development Table 100. Robinson Pharma Company Information Table 101. Robinson Pharma Business Overview Table 102. Robinson Pharma Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Robinson Pharma Plant-based Soft Capsules (Softgel) Product Portfolio Table 104. Robinson Pharma Recent Development Table 105. Aland Company Information Table 106. Aland Business Overview Table 107. Aland Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Aland Plant-based Soft Capsules (Softgel) Product Portfolio Table 109. Aland Recent Development Table 110. Fuji Capsule Company Information Table 111. Fuji Capsule Business Overview Table 112. Fuji Capsule Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Fuji Capsule Plant-based Soft Capsules (Softgel) Product Portfolio Table 114. Fuji Capsule Recent Development Table 115. Sunsho Pharmaceutical Company Information Table 116. Sunsho Pharmaceutical Business Overview Table 117. Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Product Portfolio Table 119. Sunsho Pharmaceutical Recent Development Table 120. Erkang Company Information Table 121. Erkang Business Overview Table 122. Erkang Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Erkang Plant-based Soft Capsules (Softgel) Product Portfolio Table 124. Erkang Recent Development Table 125. Baihe Group Company Information Table 126. Baihe Group Business Overview Table 127. Baihe Group Plant-based Soft Capsules (Softgel) Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Baihe Group Plant-based Soft Capsules (Softgel) Product Portfolio Table 129. Baihe Group Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Plant-based Soft Capsules (Softgel) Distributors List Table 133. Plant-based Soft Capsules (Softgel) Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Plant-based Soft Capsules (Softgel) Product Image Figure 2. Global Plant-based Soft Capsules (Softgel) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Plant-based Soft Capsules (Softgel) Sales (2021-2032) & (units) Figure 5. Global Plant-based Soft Capsules (Softgel) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Plant-based Soft Capsules (Softgel) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Carrageenan Image Figure 10. Starch Image Figure 11. Gellan Gum Image Figure 12. Global Plant-based Soft Capsules (Softgel) Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 13. Global Plant-based Soft Capsules (Softgel) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Type (2021-2032) Figure 15. Global Plant-based Soft Capsules (Softgel) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Plant-based Soft Capsules (Softgel) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Type (2021-2032) Figure 18. Rx and OTC Image Figure 19. Supplements Image Figure 20. Other Image Figure 21. Global Plant-based Soft Capsules (Softgel) Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 22. Global Plant-based Soft Capsules (Softgel) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Application (2021-2032) Figure 24. Global Plant-based Soft Capsules (Softgel) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Plant-based Soft Capsules (Softgel) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Application (2021-2032) Figure 27. Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 28. Global Plant-based Soft Capsules (Softgel) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Plant-based Soft Capsules (Softgel) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Plant-based Soft Capsules (Softgel) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Plant-based Soft Capsules (Softgel) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Plant-based Soft Capsules (Softgel) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Plant-based Soft Capsules (Softgel) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Plant-based Soft Capsules (Softgel) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Plant-based Soft Capsules (Softgel) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Plant-based Soft Capsules (Softgel) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Plant-based Soft Capsules (Softgel) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Plant-based Soft Capsules (Softgel) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Carrageenan
  • Starch
  • Gellan Gum
Applications
  • Rx and OTC
  • Supplements
  • Other
Companies covered
  • Catalent
  • Procaps Laboratorios
  • Eurocaps
  • Sirio Pharma (Best Formulations)
  • Aenova
  • Captek
  • Bahrain Pharma
  • Robinson Pharma
  • Aland
  • Fuji Capsule
  • Sunsho Pharmaceutical
  • Erkang
  • Baihe Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  4. 1.2.2 Global Plant-based Soft Capsules (Softgel) Sales Volume (2021-2032)
  5. 1.2.3 Global Plant-based Soft Capsules (Softgel) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Plant-based Soft Capsules (Softgel) Market Dynamics
  1. 2.1 Plant-based Soft Capsules (Softgel) Industry Trends
  2. 2.2 Plant-based Soft Capsules (Softgel) Industry Drivers
  3. 2.3 Plant-based Soft Capsules (Softgel) Industry Opportunities and Challenges
  4. 2.4 Plant-based Soft Capsules (Softgel) Industry Restraints
3 Plant-based Soft Capsules (Softgel) Market by Company
  1. 3.1 Global Plant-based Soft Capsules (Softgel) Company Revenue Ranking in 2025
  2. 3.2 Global Plant-based Soft Capsules (Softgel) Revenue by Company (2021-2026)
  3. 3.3 Global Plant-based Soft Capsules (Softgel) Sales Volume by Company (2021-2026)
  4. 3.4 Global Plant-based Soft Capsules (Softgel) Average Price by Company (2021-2026)
  5. 3.5 Global Plant-based Soft Capsules (Softgel) Company Ranking (2024-2026)
  6. 3.6 Global Plant-based Soft Capsules (Softgel) Company Manufacturing Base and Headquarters
  7. 3.7 Global Plant-based Soft Capsules (Softgel) Company Product Type and Application
  8. 3.8 Global Plant-based Soft Capsules (Softgel) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Plant-based Soft Capsules (Softgel) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Plant-based Soft Capsules (Softgel) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Plant-based Soft Capsules (Softgel) Market by Type
  1. 4.1 Plant-based Soft Capsules (Softgel) Type Introduction
  2. 4.1.1 Carrageenan
  3. 4.1.2 Starch
  4. 4.1.3 Gellan Gum
  5. 4.2 Global Plant-based Soft Capsules (Softgel) Sales Volume by Type
  6. 4.2.1 Global Plant-based Soft Capsules (Softgel) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Plant-based Soft Capsules (Softgel) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Plant-based Soft Capsules (Softgel) Sales Value by Type
  10. 4.3.1 Global Plant-based Soft Capsules (Softgel) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Plant-based Soft Capsules (Softgel) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Plant-based Soft Capsules (Softgel) Sales Value Share by Type (2021-2032)
5 Plant-based Soft Capsules (Softgel) Market by Application
  1. 5.1 Plant-based Soft Capsules (Softgel) Application Introduction
  2. 5.1.1 Rx and OTC
  3. 5.1.2 Supplements
  4. 5.1.3 Other
  5. 5.2 Global Plant-based Soft Capsules (Softgel) Sales Volume by Application
  6. 5.2.1 Global Plant-based Soft Capsules (Softgel) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plant-based Soft Capsules (Softgel) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Plant-based Soft Capsules (Softgel) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Plant-based Soft Capsules (Softgel) Sales Value by Application
  10. 5.3.1 Global Plant-based Soft Capsules (Softgel) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Plant-based Soft Capsules (Softgel) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Plant-based Soft Capsules (Softgel) Sales Value Share by Application (2021-2032)
6 Plant-based Soft Capsules (Softgel) Regional Sales and Value Analysis
  1. 6.1 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plant-based Soft Capsules (Softgel) Sales by Region (2021-2032)
  3. 6.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021-2026
  4. 6.2.2 Global Plant-based Soft Capsules (Softgel) Sales by Region (2027-2032)
  5. 6.3 Global Plant-based Soft Capsules (Softgel) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Plant-based Soft Capsules (Softgel) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Plant-based Soft Capsules (Softgel) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Plant-based Soft Capsules (Softgel) Sales Value by Region (2027-2032)
  9. 6.5 Global Plant-based Soft Capsules (Softgel) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  12. 6.6.2 North America Plant-based Soft Capsules (Softgel) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  15. 6.7.2 Europe Plant-based Soft Capsules (Softgel) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Plant-based Soft Capsules (Softgel) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  21. 6.9.2 South America Plant-based Soft Capsules (Softgel) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Plant-based Soft Capsules (Softgel) Sales Value Share by Country, 2025 VS 2032
7 Plant-based Soft Capsules (Softgel) Country-level Sales and Value Analysis
  1. 7.1 Global Plant-based Soft Capsules (Softgel) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plant-based Soft Capsules (Softgel) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
  4. 7.3.1 Global Plant-based Soft Capsules (Softgel) Sales by Country (2021-2026)
  5. 7.3.2 Global Plant-based Soft Capsules (Softgel) Sales by Country (2027-2032)
  6. 7.4 Global Plant-based Soft Capsules (Softgel) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Plant-based Soft Capsules (Softgel) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Plant-based Soft Capsules (Softgel) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Plant-based Soft Capsules (Softgel) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Plant-based Soft Capsules (Softgel) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Plant-based Soft Capsules (Softgel) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Catalent
  2. 8.1.1 Catalent Company Information
  3. 8.1.2 Catalent Business Overview
  4. 8.1.3 Catalent Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Catalent Plant-based Soft Capsules (Softgel) Product Portfolio
  6. 8.1.5 Catalent Recent Developments
  7. 8.2 Procaps Laboratorios
  8. 8.2.1 Procaps Laboratorios Company Information
  9. 8.2.2 Procaps Laboratorios Business Overview
  10. 8.2.3 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Product Portfolio
  12. 8.2.5 Procaps Laboratorios Recent Developments
  13. 8.3 Eurocaps
  14. 8.3.1 Eurocaps Company Information
  15. 8.3.2 Eurocaps Business Overview
  16. 8.3.3 Eurocaps Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eurocaps Plant-based Soft Capsules (Softgel) Product Portfolio
  18. 8.3.5 Eurocaps Recent Developments
  19. 8.4 Sirio Pharma (Best Formulations)
  20. 8.4.1 Sirio Pharma (Best Formulations) Company Information
  21. 8.4.2 Sirio Pharma (Best Formulations) Business Overview
  22. 8.4.3 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Product Portfolio
  24. 8.4.5 Sirio Pharma (Best Formulations) Recent Developments
  25. 8.5 Aenova
  26. 8.5.1 Aenova Company Information
  27. 8.5.2 Aenova Business Overview
  28. 8.5.3 Aenova Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aenova Plant-based Soft Capsules (Softgel) Product Portfolio
  30. 8.5.5 Aenova Recent Developments
  31. 8.6 Captek
  32. 8.6.1 Captek Company Information
  33. 8.6.2 Captek Business Overview
  34. 8.6.3 Captek Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Captek Plant-based Soft Capsules (Softgel) Product Portfolio
  36. 8.6.5 Captek Recent Developments
  37. 8.7 Bahrain Pharma
  38. 8.7.1 Bahrain Pharma Company Information
  39. 8.7.2 Bahrain Pharma Business Overview
  40. 8.7.3 Bahrain Pharma Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bahrain Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
  42. 8.7.5 Bahrain Pharma Recent Developments
  43. 8.8 Robinson Pharma
  44. 8.8.1 Robinson Pharma Company Information
  45. 8.8.2 Robinson Pharma Business Overview
  46. 8.8.3 Robinson Pharma Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Robinson Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
  48. 8.8.5 Robinson Pharma Recent Developments
  49. 8.9 Aland
  50. 8.9.1 Aland Company Information
  51. 8.9.2 Aland Business Overview
  52. 8.9.3 Aland Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Aland Plant-based Soft Capsules (Softgel) Product Portfolio
  54. 8.9.5 Aland Recent Developments
  55. 8.10 Fuji Capsule
  56. 8.10.1 Fuji Capsule Company Information
  57. 8.10.2 Fuji Capsule Business Overview
  58. 8.10.3 Fuji Capsule Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Fuji Capsule Plant-based Soft Capsules (Softgel) Product Portfolio
  60. 8.10.5 Fuji Capsule Recent Developments
  61. 8.11 Sunsho Pharmaceutical
  62. 8.11.1 Sunsho Pharmaceutical Company Information
  63. 8.11.2 Sunsho Pharmaceutical Business Overview
  64. 8.11.3 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Product Portfolio
  66. 8.11.5 Sunsho Pharmaceutical Recent Developments
  67. 8.12 Erkang
  68. 8.12.1 Erkang Company Information
  69. 8.12.2 Erkang Business Overview
  70. 8.12.3 Erkang Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Erkang Plant-based Soft Capsules (Softgel) Product Portfolio
  72. 8.12.5 Erkang Recent Developments
  73. 8.13 Baihe Group
  74. 8.13.1 Baihe Group Company Information
  75. 8.13.2 Baihe Group Business Overview
  76. 8.13.3 Baihe Group Plant-based Soft Capsules (Softgel) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Baihe Group Plant-based Soft Capsules (Softgel) Product Portfolio
  78. 8.13.5 Baihe Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Plant-based Soft Capsules (Softgel) Value Chain Analysis
  2. 9.1.1 Plant-based Soft Capsules (Softgel) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Plant-based Soft Capsules (Softgel) Sales Mode & Process
  6. 9.2 Plant-based Soft Capsules (Softgel) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Plant-based Soft Capsules (Softgel) Distributors
  9. 9.2.3 Plant-based Soft Capsules (Softgel) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst